Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT04814251
Eligibility Criteria:
Inclusion Criteria:
* Pancreatic adenocarcinoma proven histologically or cytologically in favor of pancreatic adenocarcinoma
* Mesurable disease according to RECIST 1.1 criteria or non measurable disease
* Metastatic disease (synchronous or metachronous) or locally advanced / borderline deemed unresectable and / or patient inoperable due to his co-morbidities and / or local recurrence after surgery
* Thrombosis of the main portal vein and/or of one of its branches (endo-luminal defect on the injected CTscan) of cruoric or tumoral origin or circumferential stenosis of the portal vein trunk, the spleno-mesaraic confluence or one of its venous branches with or without signs of portal hypertension on CTscan and / or upper GIendoscopy
Exclusion Criteria:
* \- Post-surgical portal vein thrombosis and / or in patients considered in remission
* Non-adenocarcinomatous pancreatic tumor (endocrine, etc.)
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT04814251
Study Brief:
Protocol Section:
NCT04814251